Financial Data
- Financial Highlights
- Financial
Position /
Cash Flows - Sales by Product
and Area - Consolidated Financial Statements
Consolidated Financial Statements
Consolidated Balance Sheets
Millons of yen, rounded down
FY2019/3 | FY2020/3 | FY2021/3 | FY2022/3 | FY2023/3 | |
---|---|---|---|---|---|
Assets | |||||
Current assets | |||||
Cash and deposits | 12,992 | 42,909 | 34,572 | 35,005 | 32,167 |
Notes and accounts receivable - trade | 39,736 | 29,718 | 30,449 | - | - |
Notes | - | - | - | 750 | 715 |
Accounts receivable - trade | - | - | - | 31,832 | 36,405 |
Securities | 42,760 | 30,653 | 38,899 | 23,999 | 23,352 |
Inventories | 11,309 | 11,205 | 14,694 | 18,001 | - |
Other | 5,067 | 5,219 | 4,868 | 5,588 | 6,439 |
Allowance for doubtful accounts | (8) | (7) | (5) | (6) | (110) |
Total current assets | 111,858 | 119,699 | 123,477 | 115,171 | 98,970 |
Non-current assets | |||||
Property, plant and equipment | 72,552 | 71,718 | 77,280 | 82,979 | 101,533 |
Buildings and structures | 28,883 | 27,983 | 29,964 | 34,020 | 34,574 |
Machinery, equipment and vehicles | 29,811 | 29,604 | 31,619 | 33,824 | 31,758 |
Land | 11,391 | 11,270 | 11,554 | 11,977 | 16,330 |
Leased assets | 228 | 446 | 403 | 458 | 480 |
Construction in progress | 1,224 | 1,508 | 2,489 | 1,255 | 16,796 |
Other | 1,012 | 905 | 1,248 | 1,442 | 1,593 |
Intangible assets | 7,704 | 13,034 | 26,497 | 26,079 | 25,932 |
Goodwill | 5,688 | 10,953 | 24,518 | 23,550 | 23,222 |
Other | 2,016 | 2,080 | 1,978 | 2,529 | 2,709 |
Investments and other assets | 10,634 | 10,515 | 11,723 | 12,368 | 12,658 |
Investment securities | 2,222 | 1,744 | 1,984 | 2,408 | 2,597 |
Long-term loans receivable | 240 | 180 | - | 100 | 100 |
Deferred tax assets | 4,421 | 4,826 | 5,352 | 5,178 | 4,955 |
Retirement benefit asset | 2,111 | 2,061 | 2,549 | 2,895 | 3,434 |
Other | 1,697 | 1,703 | 1,838 | 1,785 | 1,572 |
Allowance for doubtful accounts | (59) | (1) | (0) | (1) | (1) |
Total non-current assets | 90,891 | 95,267 | 115,501 | 121,427 | 140,124 |
Total assets | 202,750 | 214,967 | 238,978 | 236,598 | 239,095 |
Liabilities | |||||
Current liabilities | |||||
Notes and accounts payable - trade | 8,987 | 9,889 | 10,160 | 11,849 | 13,553 |
Short-term loans payable | 1,027 | 871 | 2,616 | 1,447 | 1,290 |
Current portion of long-term loans payable | - | - | 298 | - | - |
Lease obligations | 104 | 134 | 100 | 160 | 156 |
Accounts payable - other | 5,878 | 7,301 | 7,649 | 8,229 | 8,441 |
Income taxes payable | 5,478 | 4,657 | 5,153 | 4,242 | 3,702 |
Provision for bonuses | 4,004 | 4,581 | 4,916 | 4,625 | 5,398 |
Provision for bonuses for directors (and other officers) | 67 | 119 | 116 | 93 | 99 |
Provision for stocks payment | 35 | 83 | 88 | 45 | 37 |
Other | 8,459 | 8,995 | 11,484 | 11,565 | 12,983 |
Total current liabilities | 34,043 | 36,633 | 42,585 | 42,259 | 45,663 |
Non-current liabilities | |||||
Long-term loans payable | - | - | 3,166 | - | - |
Lease obligations | 111 | 325 | 383 | 375 | 403 |
Deferred tax liabilities | 622 | 367 | 793 | 906 | 1,287 |
Provisions for retirement benefits for directors (and other officers) | 286 | 330 | 358 | 334 | 323 |
Provision for management board incentive plan trust | 92 | 172 | 265 | 323 | 297 |
Retirement benefit liability | 6,531 | 6,908 | 7,846 | 8,049 | 7,523 |
Asset retirement obligations | 522 | 527 | 749 | 749 | 748 |
Other | 49 | 70 | 89 | 142 | 163 |
Total non-current liabilities | 8,216 | 8,701 | 13,652 | 10,881 | 10,745 |
Total liabilities | 42,260 | 45,334 | 56,238 | 53,140 | 56,408 |
Net assets | |||||
Shareholders' equity | |||||
Capital stock | 12,044 | 12,046 | 12,046 | 12,046 | 12,046 |
Capital surplus | 4,786 | 4,779 | 4,777 | 3,232 | 3,242 |
Retained earnings | 137,453 | 148,565 | 159,551 | 170,284 | 178,329 |
Treasury shares | (981) | (933) | (1,045) | (12,959) | (24,886) |
Total shareholders' equity | 153,303 | 164,457 | 175,329 | 172,604 | 168,730 |
Accumulated other comprehensive income | |||||
Valuation difference on available-for-sales securities | 467 | 129 | 300 | 436 | 488 |
Foreign currency translation adjustment | 278 | (833) | 562 | 3,232 | 5,225 |
Remeasurements of defined benefit plans | (119) | (511) | (822) | (893) | (332) |
Total accumulated other comprehensive income | 627 | (1,215) | 39 | 2,775 | 5,381 |
Share acquisition rights | 3 | - | - | - | - |
Non-controlling interests | 6,555 | 6,390 | 7,371 | 8,078 | 8,574 |
Total net assets | 160,490 | 169,632 | 182,740 | 183,458 | 182,686 |
Total liabilities and net assets | 202,750 | 214,967 | 238,978 | 236,598 | 239,095 |
Consolidated Statements of Income
Millons of yen, rounded down
FY2019/3 | FY2020/3 | FY2021/3 | FY2022/3 | FY2023/3 | |
---|---|---|---|---|---|
Net sales | 248,655 | 255,938 | 266,745 | 245,419 | 279,315 |
Cost of sales | 137,534 | 140,852 | 148,935 | 161,465 | 189,115 |
Gross profit | 111,120 | 115,086 | 117,810 | 83,954 | 90,200 |
Selling, general and administrative expenses | 84,156 | 87,422 | 90,746 | 58,818 | 67,967 |
Operating profit | 26,964 | 27,664 | 27,064 | 25,135 | 22,233 |
Non-operating income | |||||
Interest income | 117 | 112 | 89 | 84 | 140 |
Dividend income | 44 | 42 | 42 | 39 | 39 |
Share of profit of entities accounted for using equity method | 1 | 11 | 39 | 19 | 25 |
Foreign exchange gains | 406 | - | 452 | 1,712 | 1,125 |
Other | 281 | 434 | 305 | 242 | 263 |
Total non-operating income | 852 | 600 | 928 | 2,098 | 1,594 |
Non-operating expenses | |||||
Interest expenses | 71 | 90 | 100 | 99 | 162 |
Share of loss of entities accounted for using equity method | 10 | 2 | 143 | - | 1 |
Foreign exchange losses | - | 445 | - | - | - |
Other | 302 | 336 | 226 | 195 | 202 |
Total non-operating expenses | 384 | 873 | 470 | 295 | 366 |
Ordinary profit | 27,432 | 27,391 | 27,522 | 26,938 | 23,460 |
Extraordinary income | |||||
Gain on sales of non-current assets | 36 | 9 | 14 | 6 | 14 |
Gain on sales of shares of subsidiaries and associates | 2,378 | - | - | - | - |
Gain on sales of investment securities | 52 | 1 | 62 | 69 | 54 |
Other | 586 | 418 | 554 | 467 | 267 |
Total extraordinary income | 3,053 | 429 | 631 | 542 | 336 |
Extraordinary losses | |||||
Loss on sales of non-current assets | 16 | 50 | 57 | 23 | 35 |
Loss on retirement of non-current assets | 263 | 221 | 559 | 407 | 491 |
Impairment loss | 839 | 1,639 | - | - | 610 |
Loss on sales of shares of subsidiaries and associates | 24 | - | - | - | - |
Other | 871 | 165 | 1,155 | 302 | 18 |
Total extraordinary losses | 2,016 | 2,077 | 1,771 | 733 | 1,155 |
Profit before income taxes | 28,469 | 25,743 | 26,381 | 26,748 | 22,641 |
Income taxes - current | 9,481 | 8,925 | 8,248 | 8,024 | 7,451 |
Income taxes - deferred | (387) | (394) | 67 | 445 | 216 |
Profit | 19,375 | 17,212 | 18,065 | 18,277 | 14,973 |
Loss attributable to non-controlling interests | (53) | (327) | 383 | 224 | 201 |
Profit attributable to owners of parent | 19,429 | 17,539 | 17,682 | 18,053 | 14,772 |
Consolidated Statements of Cash Flows
Millons of yen, rounded down
FY2019/3 | FY2020/3 | FY2021/3 | FY2022/3 | FY2023/3 | |
---|---|---|---|---|---|
Cash flows from operating activities | |||||
Profit before income taxes | 28,469 | 25,743 | 26,381 | 26,748 | 22,641 |
Depreciation | 8,023 | 8,449 | 9,051 | 9,189 | 10,047 |
Impairment loss | 839 | 1,639 | - | - | 610 |
Amortization of goodwill | 758 | 714 | 1,753 | 1,819 | 1,979 |
Increase (decrease) in allowance for doubtful accounts | (14) | (57) | (13) | 1 | 86 |
Increase (decrease) in provision for bonuses | 285 | 578 | 315 | (298) | 763 |
Increase (decrease) in provision for directors’ bonuses | (32) | 56 | (9) | (26) | 6 |
Increase (decrease) in provision for stocks payment | 33 | 88 | 83 | 44 | 40 |
Increase (decrease) in provision for management board incentive plan trust | - | 87 | 92 | 58 | (3) |
Increase (decrease) in net defined benefit liability | 49 | (111) | 30 | (27) | (20) |
Decrease (increase) in net defined benefit asset | 5 | 2 | (52) | (229) | - |
Increase (decrease) in provision for directors’ retirement benefits | (146) | 43 | 27 | (23) | (256) |
Interest and dividend income | (162) | (154) | (131) | (123) | (11) |
Interest expenses | 71 | 90 | 100 | 99 | (179) |
Foreign exchange losses (gains) | (223) | 319 | (26) | (2,013) | 162 |
Subsidy income | (106) | (277) | (150) | (67) | (1,341) |
Gain on liquidation of business | (477) | - | - | - | - |
Gain on liquidation of business | - | - | (174) | - | (58) |
Share of loss (profit) of entities accounted for using equity method | 8 | (9) | 104 | (19) | (23) |
Loss (gain) on sales of investment securities | (2,405) | (1) | (61) | (60) | (54) |
Loss (gain) on valuation of investment securities | - | 18 | 29 | 76 | - |
Loss (gain) on sales of non-current assets | (20) | 41 | 43 | 17 | 21 |
Loss on retirement of non-current assets | 263 | 221 | 559 | 407 | 491 |
Decrease (increase) in notes and accounts receivable - trade | 914 | 10,092 | 476 | (1,221) | (3,987) |
Decrease (increase) in inventories | (504) | 194 | (2,026) | (2,780) | (4,915) |
Increase (decrease) in notes and accounts payable - trade | (528) | 907 | (253) | 1,002 | 1,213 |
Increase (decrease) in accounts receivable - other | 106 | (111) | 53 | 54 | 116 |
Increase (decrease) in accounts payable - other | 177 | 682 | 566 | (114) | (353) |
Increase (decrease) in accrued consumption taxes | (402) | (268) | (114) | 19 | 388 |
Other, net | 1,779 | 614 | 1,899 | (1,282) | 111 |
Subtotal | 36,760 | 49,592 | 38,555 | 31,248 | 27,473 |
Interest and dividend income received | 149 | 154 | 131 | 120 | 189 |
Interest expenses paid | (71) | (88) | (108) | (106) | (169) |
Income taxes paid | (9,218) | (9,209) | (8,128) | (8,934) | (8,182) |
Net cash provided by (used in) operating activities | 27,620 | 40,449 | 30,450 | 22,327 | 19,310 |
Cash flows from investing activities | |||||
Purchase of property, plant and equipment | (9,390) | (8,392) | (10,715) | (12,491) | (25,750) |
Proceeds from sales of property, plant and equipment | 235 | 109 | 17 | 15 | 12 |
Purchase of intangible assets | (555) | (612) | (626) | (1,024) | (966) |
Proceeds from sales of intangible assets | 0 | - | - | - | - |
Purchase of securities | (39,425) | (55,035) | (44,896) | (26,998) | (13,998) |
Proceeds from redemption of securities | 23,826 | 57,335 | 36,182 | 43,900 | 23,000 |
Purchase of investment securities | (45) | (15) | (187) | (435) | (209) |
Proceeds from sales of investment securities | 93 | 5 | 121 | 218 | 248 |
Payments of loans receivable | (980) | (700) | (700) | (100) | - |
Collection of loans receivable | 2,378 | 800 | 1,460 | 180 | 78 |
Payments into time deposits | (730) | (2,253) | (968) | (925) | (5,243) |
Proceeds from withdrawal of time deposits | 355 | 2,336 | 1,318 | 922 | 3,713 |
Payments for guarantee deposits | (89) | (99) | (84) | (54) | (86) |
Proceeds from collection of guarantee deposits | 128 | 89 | 56 | 382 | 71 |
Purchase of shares of subsidiaries resulting in change in scope of consolidation | (7,351) | (7,305) | (13,194) | - | (1,555) |
Payments for sales of shares of subsidiaries resulting in change in scope of consolidation | (460) | - | - | - | - |
Proceeds from sales of shares of subsidiaries resulting in change in scope of consolidation | 3,169 | - | - | - | - |
Proceeds from subsidy income | 106 | 277 | 150 | 52 | 58 |
Other, net | 387 | (2) | (3) | 2 | 296 |
Net cash provided by (used in) investing activities | (28,347) | (13,462) | (32,069) | 3,643 | (20,329) |
Cash flows from financing activities | |||||
Net increase (decrease) in short-term borrowings | (509) | (11) | (490) | (1,300) | (235) |
Repayment of long-term borrowings | - | - | (298) | (3,465) | (535) |
Purchase of treasury shares | - | (0) | (191) | (12,000) | (11,999) |
Proceeds from exercise of share options | 18 | 3 | - | - | - |
Proceeds from share issuance to non-controlling shareholders | - | 323 | 139 | 461 | (201) |
Cash dividends paid | (5,621) | (6,425) | (6,693) | (6,692) | (6,723) |
Dividends paid to non-controlling interests | (10) | (11) | (12) | (222) | 445 |
Repayments of lease obligations | (104) | (156) | (87) | (67) | (754) |
Payments from changes in ownership interests in subsidiaries that do not result in change in scope of consolidation | - | - | - | (1,882) | 0 |
Net cash provided by (used in) financing activities | (6,227) | (6,278) | (7,635) | (25,168) | (20,004) |
Effect of exchange rate change on cash and cash equivalents |
184 | (390) | 793 | 1,585 | 1,645 |
Net increase (decrease) in cash and cash equivalents | (6,769) | 20,317 | (8,460) | 2,388 | (19,378) |
Cash and cash equivalents at beginning of period | 42,195 | 35,425 | 55,742 | 47,282 | 49,670 |
Cash and cash equivalents at end of period | 35,425 | 55,742 | 47,282 | 49,670 | 30,292 |